A multidisciplinary team made up of veterinarians, pharmacists and Doctors of microbiology.
15% of the turnover at Ceva Biovac is allocated to research both in vivo and in vitro.
CEVA BIOVAC MEASURES THE EFFICACY OF ITS AUTOGENOUS VACCINES AND EVALUATES THE VACCINATION PROGRAMMES IN TRIALS CONDUCTED BOTH IN THE LABORATORY AND IN THE FIELD ON AN ONGOING BASIS
Clinical studies are performed, both in the laboratory and in the field, with the support of a network of veterinarians who use the vaccines.
Research protocols are regularly implemented with private or public organisations such as AFSSA [French Food Safety Agency], INRA [French National Institute for Agricultural Research] or ENV. These studies are the subject of communications in specialised journals and are presented at symposia and professional meetings.
Research programmes are also conducted at the request of or in collaboration with pharmaceutical companies, research institutes, professional organisations, societies in the field of animal production and veterinary practices.
To ensure that the studies undertaken are completely reliable, Ceva Biovac complies with Good Laboratory Practice (G.L.P.).
The results of these studies are published on a regular basis.
Its microbiology know-how has motivated Ceva Biovac to develop a range of reagents for serological diagnosis of bacterial infections which is intended to veterinary laboratories and represents a valuable aid to diagnosis.
Ceva Biovac also supplies its expertise in bacteriology to veterinarians and laboratories for the purposes of the identification and typing of many bacterial strains.
For further information, contact us.